GYPA and Alzheimer disease: Flow cytometry analysis showed that AD-MSCs were more than 98% positive for CD29, CD13, CD105, CD73, and CD90, and less than 1% positive for CD235a, CD31 and CD45 (Fig 1C), indicating that the isolated cells had the typical MSC phenotype.